This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Judy St. Petery, MD; Cordell Gross, MD; Benjamin E. Victorica, MD

Am J Dis Child. 1970;120(4):367-371.

Abstract
Management of a patient with ventricular fibrillation associated with arsenic poisoning consisted of an intravenous pacemaker with dimercaprol (BAL) and procainamide hydrochloride therapy. She presented with the characteristic clinical features seen in patients with acute and subacute arsenical poisoning. They consist of acute gastrointestinal upset followed by the appearance of peripheral polyneuropathy and Mees' lines in all fingernails. The value of neutron activation analysis in the investigation of arsenic poisoning is confirmed. After the episode of ventricular fibrillation, the electrocardiogram showed nonspecific ST segment changes and prolongation of the Q-T_c interval. In cases of arsenic poisoning, particular attention should be given to the cardiovascular manifestations. Therapy should also be directed toward averting potentially fatal arrhythmias.

Author Affiliations
Gainesville, Fla

From the Department of Pediatrics, University of Florida College of Medicine, Gainesville, Fla.

Footnotes
Received for publication May 1, 1970.

Reprint requests to Department of Pediatrics, University of Florida College of Medicine, Gainesville, Fla 32601.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mechanisms of Arsenic-Induced Prolongation of Cardiac Repolarization
Ficker et al.
Mol. Pharmacol. 2004;66:33-44.
ABSTRACT | FULL TEXT  

Effect of Arsenic Trioxide on QT Interval in Patients With Advanced Malignancies
Barbey et al.
JCO 2003;21:3609-3615.
ABSTRACT | FULL TEXT  

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide
Westervelt et al.
Blood 2001;98:266-271.
ABSTRACT | FULL TEXT  

Prolongation of the QT Interval and Ventricular Tachycardia in Patients Treated with Arsenic Trioxide for Acute Promyelocytic Leukemia
Ohnishi et al.
ANN INTERN MED 2000;133:881-885.
ABSTRACT | FULL TEXT